Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomised Double-Blind Multicentre Equivalence Study With Active Parallel Comparator Group to Evaluate the Efficacy and Safety of Norspan Patches Versus Tramadol in Subjects With Chronic Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine.

Next Previous
X
Search
Trial Profile

A Randomised Double-Blind Multicentre Equivalence Study With Active Parallel Comparator Group to Evaluate the Efficacy and Safety of Norspan Patches Versus Tramadol in Subjects With Chronic Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Aug 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Buprenorphine (Primary) ; Tramadol
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Norpharma

    • Most Recent Events

    • 02 Feb 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 29 Jan 2010 Status changed from recruiting to completed, as reported in ClinicalTrials.gov record.
    • 14 Jan 2008 Status changed from initiated to recruiting according to ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top